Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, June 2002, p. 1695-1703, Vol. 46, No. 6
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.6.1695-1703.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Molecular Mechanisms of Fluconazole Resistance in Candida dubliniensis Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis
Sofia Perea,1 José L. López-Ribot,1* Brian L. Wickes,2 William R. Kirkpatrick,1 Olga P. Dib,1 Stefano P. Bachmann,1 Suzanne M. Keller,2 Marcos Martinez,1 and Thomas F. Patterson1,3
Department of Medicine, Division of Infectious Diseases,1
Department of Microbiology, The University of Texas Health Science Center at San Antonio,2
Audie L. Murphy Division, South Texas Veterans Health Care System, San Antonio, Texas3
Received 26 June 2001/
Returned for modification 20 July 2001/
Accepted 4 February 2002
Candida dubliniensis is a newly identified species of Candida that is phenotypically similar to but genetically distinct from C. albicans. This organism has been recovered with increasing frequency from the oral cavities of human immunodeficiency virus (HIV)-infected and AIDS patients and has been implicated as a causative agent of oral candidiasis and systemic disease. In the present study we characterized the molecular mechanisms of resistance to fluconazole (FLC) in C. dubliniensis clinical isolates from two different HIV-infected patients with oropharyngeal candidiasis. Isolates were identified to the species level by phenotypic and genotypic tests. DNA-typing techniques were used to assess strain identity. Antifungal susceptibility testing was performed by NCCLS techniques. Northern blotting analysis was used to monitor the expression of genes encoding lanosterol demethylase (ERG11) and efflux transporters (CDR and MDR1) in matched sets of C. dubliniensis-susceptible and -resistant isolates by using probes generated from their homologous C. albicans sequences. In addition, ERG11 genes were amplified by PCR, and their nucleotide sequences were determined in order to detect point mutations with a possible effect in the affinity for azoles. Decreasing susceptibilities to FLC were detected in C. dubliniensis isolates recovered from both patients during the course of treatment. FLC-resistant C. dubliniensis isolates from one patient demonstrated combined upregulation of the MDR1, CDR1, and ERG11 genes. Among the isolates from the second patient, all isolates showing decreased susceptibility to FLC demonstrated upregulation of MDR1, whereas the levels of mRNA for the ERG11 genes remained constant and the expression of CDR genes was negligible. Fourteen point mutations were found in the ERG11 genes of the isolates with decreased susceptibility to FLC. These data demonstrate that the development of azole resistance in C. dublinensis clinical isolates from HIV-infected patients treated with FLC is mediated by multiple molecular mechanisms of resistance, similar to the observations found in the case of C. albicans.
* Corresponding author. Mailing address: Department of Medicine, Division of Infectious Diseases, The University of Texas Health Science Center at San Antonio, South Texas Centers for Biology in Medicine, Texas Research Park, 15355 Lambda Drive, San Antonio, TX 78245. Phone: (210) 562-5017. Fax: (210) 562-5016. E-mail: RIBOT{at}UTHSCSA.EDU.
Antimicrobial Agents and Chemotherapy, June 2002, p. 1695-1703, Vol. 46, No. 6
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.6.1695-1703.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Szabo, Z., Toth, B., Kovacs, M., Kardos, G., Maraz, A., Rozgonyi, F., Majoros, L.
(2008). Evaluation of the New Micronaut-Candida System Compared to the API ID32C Method for Yeast Identification. J. Clin. Microbiol.
46: 1824-1825
[Abstract]
[Full Text]
-
Coste, A., Selmecki, A., Forche, A., Diogo, D., Bougnoux, M.-E., d'Enfert, C., Berman, J., Sanglard, D.
(2007). Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates. Eukaryot Cell
6: 1889-1904
[Abstract]
[Full Text]
-
MacPherson, S., Akache, B., Weber, S., De Deken, X., Raymond, M., Turcotte, B.
(2005). Candida albicans Zinc Cluster Protein Upc2p Confers Resistance to Antifungal Drugs and Is an Activator of Ergosterol Biosynthetic Genes. Antimicrob. Agents Chemother.
49: 1745-1752
[Abstract]
[Full Text]
-
Pinjon, E., Jackson, C. J., Kelly, S. L., Sanglard, D., Moran, G., Coleman, D. C., Sullivan, D. J.
(2005). Reduced Azole Susceptibility in Genotype 3 Candida dubliniensis Isolates Associated with Increased CdCDR1 and CdCDR2 Expression. Antimicrob. Agents Chemother.
49: 1312-1318
[Abstract]
[Full Text]
-
Pancholi, P., Park, S., Perlin, D., Kubin, C., Della-Latta, P.
(2004). Molecular Characterization of Fluconazole Resistance in a Case of Candida albicans Ocular Infection. J. Clin. Microbiol.
42: 5938-5939
[Abstract]
[Full Text]
-
Coste, A. T., Karababa, M., Ischer, F., Bille, J., Sanglard, D.
(2004). TAC1, Transcriptional Activator of CDR Genes, Is a New Transcription Factor Involved in the Regulation of Candida albicans ABC Transporters CDR1 and CDR2. Eukaryot Cell
3: 1639-1652
[Abstract]
[Full Text]
-
Vermitsky, J.-P., Edlind, T. D.
(2004). Azole Resistance in Candida glabrata: Coordinate Upregulation of Multidrug Transporters and Evidence for a Pdr1-Like Transcription Factor. Antimicrob. Agents Chemother.
48: 3773-3781
[Abstract]
[Full Text]
-
Moran, G., Stokes, C., Thewes, S., Hube, B., Coleman, D. C., Sullivan, D.
(2004). Comparative genomics using Candida albicans DNA microarrays reveals absence and divergence of virulence-associated genes in Candida dubliniensis. Microbiology
150: 3363-3382
[Abstract]
[Full Text]
-
Brun, S., Berges, T., Poupard, P., Vauzelle-Moreau, C., Renier, G., Chabasse, D., Bouchara, J.-P.
(2004). Mechanisms of Azole Resistance in Petite Mutants of Candida glabrata. Antimicrob. Agents Chemother.
48: 1788-1796
[Abstract]
[Full Text]
-
Pinjon, E., Moran, G. P., Jackson, C. J., Kelly, S. L., Sanglard, D., Coleman, D. C., Sullivan, D. J.
(2003). Molecular Mechanisms of Itraconazole Resistance in Candida dubliniensis. Antimicrob. Agents Chemother.
47: 2424-2437
[Abstract]
[Full Text]
-
Redding, S. W., Kirkpatrick, W. R., Saville, S., Coco, B. J., White, W., Fothergill, A., Rinaldi, M., Eng, T., Patterson, T. F., Lopez-Ribot, J.
(2003). Multiple Patterns of Resistance to Fluconazole in Candida glabrata Isolates from a Patient with Oropharyngeal Candidiasis Receiving Head and Neck Radiation. J. Clin. Microbiol.
41: 619-622
[Abstract]
[Full Text]
-
Martinez, M., Lopez-Ribot, J. L., Kirkpatrick, W. R., Coco, B. J., Bachmann, S. P., Patterson, T. F.
(2002). Replacement of Candida albicans with C. dubliniensis in Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis Treated with Fluconazole. J. Clin. Microbiol.
40: 3135-3139
[Abstract]
[Full Text]
Copyright © 2002 by the American Society for Microbiology. All rights reserved.